News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
EVO under $10
EVO 10Q due 3/25
Next day settlement begins 5/28 per SEC mandate
[-chart]www.stockscores.com/chart.asp?TickerSymbol=EVO&TimeRange=950&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&avgType1=&movAvg1=&avgType2=&movAvg2=&candles=redgreen[/chart]
|
Followers
|
1
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
16
|
|
Created
|
11/03/23
|
Type
|
Free
|
| Moderators | |||
Manfred Eigen Campus
Essener Bogen 7
Hamburg 22419
Germany
49 40 560810
info@evotec.comABOUT EVOTEC SE
Evotec is a life science company with a unique business model that delivers on its mission to discover
and develop highly effective therapeutics and make them available to the patients.
The Company's multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development,
and production of first-in-class and best-in-class pharmaceutical products.
Evotec leverages this "Data-driven R&D Autobahn to Cures" for proprietary projects and within a network of partners including all Top 20 Pharma
and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders.
Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases.
Within these areas of expertise, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics and has to-date established a portfolio of more than 200 proprietary
and co-owned R&D projects from early discovery to clinical development. Evotec operates globally with more than 5,000 highly qualified people.
The Company's 17 sites offer highly synergistic technologies and services and operate as complementary clusters of excellence. For additional information
please go to www.evotec.com and follow us on X/Twitter @Evotec and LinkedIn .
EVT EXECUTE EVT EXECUTECYPROTEXDRUG DISCOVERY SERVICESBIOTHERAPEUTICSEVOTEC GENE THERAPYINTEGRATED PRE-CLINICAL DEVELOPMENTINTEGRATED CMCINDIGOCLINICAL DEVELOPMENTGLOBAL REGULATORY AFFAIRS SUPPORTINTEGRATED DRUG DISCOVERYTHERAPEUTIC AREASEVT EXECUTE ALLIANCES PER IHUB MGMT
DISCLAIMER: ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*The Board Monitor and herewithin , are not licensed brokers and assume NO responsibility for actions,
investments,decisions, or messages posted on this forum.
CONTENT ON THIS FORUM SHOULD NOT BE CONSIDERED ADVISORY NOR SOLICITATION
AUTHORS MAY HAVE BUYS OR SELLS WITH THE COMPANIES MENTIONED IN TRADING POSTERS SHOULD DUE DILIGENT BUYING OR SELLING.
ALL POSTING SHOULD BE CONSIDERED FOR INFORMATION ONLY. WE DO NOT RECOMMEND ANYONE BUY OR SELL ANY SECURITIES POSTED HEREWITHIN.
ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.Any
